European Psychiatry (Mar 2023)

Aripriprazole induced severe oculogyric dystonia treated with electroconvulsive therapy(ECT)

  • K. Bhat Shah,
  • T. S. Bhat,
  • J. S. Pawar,
  • N. Pande

DOI
https://doi.org/10.1192/j.eurpsy.2023.2142
Journal volume & issue
Vol. 66
pp. S1009 – S1009

Abstract

Read online

Introduction Aripiprazole is the third generation Antipsychotic, and Dopamine serotonin system stabiliser.It is partial agonist at D2 and 5 HT1 A and antagonist at 5 HT2.Most commonly seen adverse effects are Akathesia, fatugue,insomnia and headache the major advanatage is less propensity for extrapyramidal side effects and lmetabolic side eefects. Objectives To report a case of Schizophrenia treated with Aripiprazole 15mg/day developiing occular gyric crisis which was tratment resistant. Methods We administered Electroconvulsvive therapy, bidirectional brief pulse constant current 8 ECTS, under General anesthesia with medical fitness . Results Patient Showed complete resolution of Dystonia after second ECTs and Showed improvment in Pyschosis Parameterd. Assessment using Naranjo Protocol made. Conclusions Electroconvulsive therapy therapy is viable alternative to manage Dystonia when medical treatment fails Disclosure of Interest None Declared